Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum

CONCLUSION: Integrated use of structural, metabolic, molecular (Aβ) and perfusion (CBF) parameters contribute to the discrimination of SCD, aMCI, and ADD.PMID:38050727 | DOI:10.2174/0115672050243131230925034334

Source: Current Alzheimer Research - December 5, 2023 Category: Neurology Authors: Lutfiye Ozlem Atay Esen Saka Umit Ozgur Akdemir Ezgi Yetim Erdem Balc ı Ethem Murat Arsava Mehmet Akif Topcuoglu Source Type: research